106190 — High Tech Pharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual balance sheet for High Tech Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,637	7,880	5,365	7,759	14,430
Net Total Accounts Receivable
Net Total Receivables	9,472	28,555	24,483	20,357	11,354
Total Inventory
Prepaid Expenses
Total Current Assets	40,488	52,040	56,571	64,234	70,991
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	80,544	74,934	75,001	72,002	68,854
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	122,937	132,202	135,058	140,090	143,697
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22,703	31,738	22,785	18,946	12,519
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	29,052	32,263	28,064	20,352	13,025
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	93,885	99,939	106,994	119,738	130,671
Total Liabilities & Shareholders' Equity	122,937	132,202	135,058	140,090	143,697
Total Common Shares Outstanding